NEW YORK (Reuters Health) – Compared with antenatal vaginal cultures, intrapartum PCR screening for maternal group B streptococcal colonization reduces the rate of neonatal GBS disease, a French…
NEW YORK (Reuters Health) – While first-void urine specimens have been used traditionally to test for Chlamydia trachomatis, newer DNA detection methods produce reliable results using midstream specimens,…
NEW YORK (Reuters Health) – In patients presenting with chest pain, troponin I levels measured on admission and at 3 hours reliably rule out or rule in acute…
NEW YORK (Reuters Health) – Testing for autoantibody against the 155-kDa protein is a “highly accurate” tool for diagnosing cancer-associated myositis in adults with dermatomyositis, according to a…
NEW YORK (Reuters Health) – The Oncotype DX test, based on reverse transcription polymerase chain reaction (RT-PCR), for HER2 gene amplification in breast cancers has an “unacceptable” false-negative…
NEW YORK (Reuters Health) – While real-time polymerase chain reaction (RT-PCR) testing is sensitive and rapid in diagnosing the cause of acute respiratory infection in children, it does…
NEW YORK (Reuters Health) – Quantitative Pneumocystis jirovecii (Pj) PCR can be a valuable diagnostic tool in immunocompromised non-HIV patients, Swiss researchers report in a September 15th on-line…
NEW YORK (Reuters Health) – BRCA2, but not BRCA1, gene mutation is associated with improved survival and response to chemotherapy in women with high-grade serous ovarian cancer, an…
NEW YORK (Reuters Health) – The sensitivity of currently available PCR-based assays for diagnosing sepsis in newborns is not yet high enough to replace microbial cultures, according to…
NEW YORK (Reuters Health) – A large increase in the number of lymph nodes evaluated during surgery for colon cancer — a quality improvement metric– has not had…